Dr Peter Yellowlees reviews an observational study from Sweden evaluating the effect of commonly used psychiatric medications on mortality in patients with schizophrenia.

By leading an unprecedented group of companies, institutions, and scientists in Cancer Moonshot 2020, Patrick Soon-Shiong has set out to change cancer care forever. Here's how he plans to do it.

The 2016 USPSTF recommendations for use of aspirin for primary prevention are just out and should make life easier for primary care clinicians.

Dr Barry Carter discusses a trial suggesting that pharmacists working in primary care offices can help with difficult hypertension cases, and the cost-effectiveness of bringing on a pharmacist.

Dr Ting talks with Dr Wilner about the results of her study on the bioequivalence of generic and brand-name drugs for epilepsy.

Dr Peter Yellowlees comments on research that finally settles the question of whether statin use lowers the incidence of dementia.

Keeping up with the changes to adult immunization schedules can be onerous…unless you have this quick summary of what's new for 2016!

Dr Jacobs discusses a new therapeutic class of agents for migraine prevention and some phase 2 results.

Past AACR president Dr Carlos Arteaga describes translational studies and emerging therapies that are transforming the clinical practice of breast cancer.

Regional variation in therapeutic decision-making and clinical practice prompts Dr O'Donoghue to question what affects her choices.